BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Coherus to Report First Quarter 2025 Financial Results on May 12, 2025

  May 5, 2025

   · 

  2 min read
• Press Releases

  Syndax Reports First Quarter 2025 Financial Results and Provides Business Update

  May 5, 2025

   · 

  17 min read
• Press Releases

  Phanes Therapeutics announces first patient dosed in clinical study of peluntamig in combination with atezolizumab

  May 5, 2025

   · 

  2 min read
• Press Releases

  Neurocrine Biosciences Reports First Quarter 2025 Financial Results and Reaffirms 2025 Financial Guidance

  May 5, 2025

   · 

  16 min read
• Press Releases

  Acadia Pharmaceuticals to Participate in the BofA Securities 2025 Health Care Conference

  May 5, 2025

   · 

  1 min read
• Press Releases

  CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

  May 5, 2025

   · 

  11 min read
• Press Releases

  Vertex Reports First Quarter 2025 Financial Results

  May 5, 2025

   · 

  20 min read
• Press Releases

  LeMaitre to Present at the Bank of America Securities 2025 Healthcare Conference

  May 5, 2025

   · 

  1 min read
• Press Releases

  Atara Biotherapeutics Provides Regulatory Updates on EBVALLO™ (tabelecleucel)

  May 5, 2025

   · 

  6 min read
• Press Releases

  Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Chamber Trial of Reproxalap and Plans NDA Resubmission

  May 5, 2025

   · 

  9 min read